Vanguard Group Inc. Purchases 434,336 Shares of Omnicell, Inc. (NASDAQ:OMCL)

Vanguard Group Inc. lifted its holdings in Omnicell, Inc. (NASDAQ:OMCL) by 8.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,571,420 shares of the company’s stock after acquiring an additional 434,336 shares during the period. Vanguard Group Inc. owned approximately 12.13% of Omnicell worth $209,653,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Hsbc Holdings PLC bought a new stake in Omnicell in the third quarter valued at $200,000. Acadian Asset Management LLC acquired a new position in Omnicell during the 3rd quarter worth approximately $62,000. Tower Research Capital LLC TRC boosted its holdings in Omnicell by 31.6% in the third quarter. Tower Research Capital LLC TRC now owns 7,615 shares of the company’s stock worth $343,000 after acquiring an additional 1,829 shares in the last quarter. Teza Capital Management LLC acquired a new stake in Omnicell in the third quarter valued at approximately $257,000. Finally, Gotham Asset Management LLC grew its stake in Omnicell by 4.7% in the third quarter. Gotham Asset Management LLC now owns 8,120 shares of the company’s stock valued at $366,000 after acquiring an additional 368 shares during the period. 97.70% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Benchmark reissued a “buy” rating and issued a $38.00 price target on shares of Omnicell in a research report on Tuesday, April 30th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $42.20.

Omnicell Stock Down 1.8 %

Omnicell stock opened at $26.16 on Wednesday. The firm has a market capitalization of $1.20 billion, a price-to-earnings ratio of -56.87, a P/E/G ratio of 95.99 and a beta of 0.80. The firm has a 50 day simple moving average of $29.36 and a 200 day simple moving average of $30.29. Omnicell, Inc. has a 1-year low of $25.45 and a 1-year high of $75.07. The company has a current ratio of 2.38, a quick ratio of 2.13 and a debt-to-equity ratio of 0.48.

Omnicell (NASDAQ:OMCL) last announced its quarterly earnings results on Thursday, May 2nd. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.17. Omnicell had a positive return on equity of 2.41% and a negative net margin of 1.91%. The company had revenue of $246.15 million during the quarter, compared to analysts’ expectations of $235.70 million. On average, analysts predict that Omnicell, Inc. will post 0.2 earnings per share for the current year.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.